posted on 2004-03-25, 00:00authored byLifen Xu, Santosh S. Kulkarni, Sari Izenwasser, Jonathan L. Katz, Theresa Kopajtic, Stacey A. Lomenzo, Amy Hauck Newman, Mark L. Trudell
3β-Aryltropane analogues wherein the 2-position was substituted with various diarylmethoxyalkyl groups were synthesized and evaluated for binding at the dopamine transporter (DAT),
serotonin transporter (SERT), norepinephrine transporter (NET), and muscarinic (M1) receptors.
The 2β-analogues 9a−i generally demonstrated high to moderate binding affinities (Ki = 34−112 nM) at the DAT with good selectivity over SERT, NET, and M1 receptors. Alternatively,
the 2α-isomers 10a−i were 10-fold less potent at the DAT with poor selectivity over SERT.
These SAR studies provide further evidence for the varied binding requirements of structurally
diverse tropane-based ligands and support future studies to elucidate DAT binding requirements
in relation to cocaine-like behavioral endpoints.